AV
Avacta Group Plc
AVCTF · OTC
$0.97 +1.57% (+$0.02)
1M +7.78%
Market Cap £336.5M
P/E Ratio -
Div. Yield -
ROE 255.53%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 2,978.60x
P/B 135.94x
P/E N/A
Growth
0 /100
Declining Rev. growth 77.30%
Book val. growth 48.79%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 1,031.86%
Net margin 33,961.30%
FCF margin 21,950.60%
Quality
0 /100
Poor ROIC 172.01%
ROE 255.53%
Asset turnover 0.00x
Debt
7 /100
High Debt/Equity 6.02x
Current ratio 0.89x
Int. coverage -4.29x
Stability
19 /100
Unstable Beta -0.10x
Rev. volatility 120.76%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o AVCTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christina Marie Coughlin
Employees
154
Headquarters
London
Nadchodzące wydarzenia
05 PAŹ
Earnings
Upcoming earnings report